Suppr超能文献

急性肠系膜缺血的开放和血管内治疗:系统评价。

Open and Endovascular Management of Acute Mesenteric Ischaemia: A Systematic Review.

机构信息

Departments of General Surgery, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

Departments of Surgery, Maastricht University, Maastricht, The Netherlands.

出版信息

World J Surg. 2019 Dec;43(12):3224-3231. doi: 10.1007/s00268-019-05149-x.

Abstract

BACKGROUND

Acute mesenteric ischaemia (AMI) is a life-threatening surgical emergency resulting from thromboembolic occlusion of the mesenteric vasculature. Traditional management of AMI has been open revascularisation with or without bowel resection-a procedure which carries considerable morbidity and mortality in an already unwell, compromised patient. Endovascular and more minimally invasive management approaches to AMI have been reported. Proponents of endovascular management suggest this approach may be associated with reduced morbidity and mortality compared with open surgery.

OBJECTIVES

To assess the impact of endovascular approach for AMI on mortality and need for subsequent laparotomy and/or bowel resection.

DATA SOURCES

The search bodies PubMed and Medline were interrogated.

ELIGIBILITY CRITERIA, PARTICIPANTS AND INTERVENTIONS: All studies in English with greater than 10 patients examining outcomes for patients undergoing endovascular intervention for acute mesenteric ischaemia were included. All patients over 18 years presenting with a diagnosis of acute mesenteric ischaemia secondary to an arterial thromboembolic source were included. Studies examining endovascular intervention alone or endovascular and open intervention were selected.

RESULTS

The 30-day mortality for endovascular approach from all 13 studies was 16-42%. Of the 7 comparative studies including results of open revascularisation, the 30-day mortality for patient treated with an endovascular approach was 15-39% versus 33-50% for open revascularisation. Laparotomy rates post-initial endovascular intervention ranged from 13 to 73%. Bowel resection post-endovascular therapy ranged from 14 to 40% among studies. Concerning 7 comparative studies for open versus endovascular revascularisation, the rate of bowel resection in the endovascular group ranged 14-28% and 33-63% in the open cohort. Endovascular intervention also demonstrated lower median length (s) of bowel resected.

LIMITATIONS

Heterogeneity of studies and patient populations studied including selection bias.

CONCLUSIONS AND IMPLICATIONS OF FINDINGS

Endovascular management may be associated with reduced mortality and need for/length of bowel resection compared with the traditional open approach, but there remains a paucity of robust data to support this. The available literature illustrates that a subgroup of patients without haemodynamic compromise and more insidious onset may garner benefit from endovascular intervention.

摘要

背景

急性肠系膜缺血(AMI)是一种危及生命的外科急症,由肠系膜血管血栓栓塞引起。AMI 的传统治疗方法是开放再血管化,伴或不伴肠切除术 - 对于已经身体不适和身体状况受损的患者,这一手术过程存在相当大的发病率和死亡率。已经报道了针对 AMI 的血管内和更微创的治疗方法。血管内治疗的支持者认为,与开放手术相比,这种方法可能与降低发病率和死亡率相关。

目的

评估血管内方法治疗 AMI 对死亡率以及随后进行剖腹手术和/或肠切除术的需求的影响。

数据来源

检索了 PubMed 和 Medline 这两个搜索机构。

入选标准、参与者和干预措施:所有纳入的研究均为英文,患者数量超过 10 例,评估了接受急性肠系膜缺血血管内干预的患者的结局。所有患者均超过 18 岁,诊断为急性肠系膜缺血,病因是动脉血栓栓塞源。选择了仅研究血管内干预或血管内和开放干预的研究。

结果

来自 13 项研究的血管内治疗的 30 天死亡率为 16-42%。在包括开放再血管化结果的 7 项比较研究中,接受血管内治疗的患者的 30 天死亡率为 15-39%,而开放再血管化的死亡率为 33-50%。初始血管内干预后的剖腹手术率为 13-73%。血管内治疗后的肠切除率在各研究中为 14-40%。对于 7 项比较开放与血管内再血管化的研究,血管内组的肠切除率为 14-28%,开放组为 33-63%。血管内干预还显示切除的肠段中位数(s)更短。

局限性

研究和研究人群的异质性,包括选择偏倚。

结论和发现的意义

与传统的开放方法相比,血管内治疗可能与降低死亡率和减少肠切除的需求/长度相关,但目前缺乏强有力的数据支持这一点。现有文献表明,没有血流动力学受损和更隐匿性发病的亚组患者可能从血管内干预中获益。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验